Skip to main content
Clinical Trials/IRCT2017041720258N37
IRCT2017041720258N37
Recruiting
Phase 2

Evaluation of Fluoxetine and standard treatment efficacy on change to side effect of stroke of ischemic strokes in both hemisphers in anterior circulation

Vice chancellor for research, Arak University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Ischemic strokes.
Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Enrollment
60
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Vice chancellor for research, Arak University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • 40\-70 years; both of gender; lack of history ischemic strokes and nerve focal defect in last; nerve focal defect in recent ischemic strokes; compatibility clinical symptoms of stroke and place conflict brain imaging; select patient in 2\-7 days after start ischemic strokes
  • Exclusion criteria: unavailability of patient during study period; history of side effect of Fluoxetine and other anti psychotic drugs; pregnant woman; lactating women; depression and recent depression in one month ago and treatment with anti psychotic drugs; use Monoamine oxidase inhibitorin five months ago

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials